Published on 28 January 2025
Description:
The great table of debate has been pulled up, as argument and counter argument wrestle for supremacy in the first tubthumping PharmaTimes of the year. Indeed, we stare down all the most pressing issues of 2025 including AI, modern comms, misinformation, mass screening, weight loss drugs, the future of the NHS, digital drugs and the promised land of patient inclusivity. Yep, this year – more than any other in human history
Categories:
PharmaTimesPreview:
26 articles from this collection:
January/February 2025 - Cover
INTCR AWARDS 2025
From the editor
Contents
NEWS: Treatments
NEWS: Collaborations
NEWS: Innovation
NEWS: Conditions
COVER STORY - Alive in ’25!
DIAGNOSIS - On the bright side
DIVERSITY - Research resolutions
FlyPharma Amsterdam 2025
Market Pharmaceutical
THOUGHT LEADER - To be precise
COLUMN - Withering heights
PHARMA - Test of trust
DIGITAL - Design for life
RARE DISEASE - No patient left behind
CONDITIONS - Give us a clue
TREATMENT - Healthcare balancing act
PHARMACY - Super pharma?
CONDITIONS - New view for future crew
Your moves
AI - Clins and outs
MSEA
USCROY
PharmaTimes
PharmaTimes is the UK’s leading pharmaceutical magazine, tracking the trends and issues that affect the industry here in the UK, in Europe and across the world. We deliver independent, authoritative and trustworthy content through impartial, balanced and informed opinion and analysis.